Filing Details
- Accession Number:
- 0001179110-18-004910
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-29 16:19:07
- Reporting Period:
- 2018-03-27
- Accepted Time:
- 2018-03-29 16:19:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc | HQY | Services-Business Services, Nec (7389) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1703205 | D Gary Robinson | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Evp, Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-27 | 1,350 | $0.00 | 3,369 | No | 4 | A | Direct | |
Common Stock | Disposition | 2018-03-27 | 182 | $63.50 | 3,187 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-03-27 | 1,000 | $41.28 | 4,187 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-27 | 1,000 | $63.02 | 3,187 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2018-03-27 | 1,000 | $0.00 | 1,000 | $41.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,000 | 2027-03-27 | No | 4 | M | Direct |
Footnotes
- Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 338 shares on each of March 27, 2019 and 2020, and 337 shares on each of March 27, 2021 and 2022.
- The option became exercisable as to 5,000 shares on March 27, 2018. The remaining shares become exercisable in three equal annual installments of 5,000 shares on March 27, 2019, 2020 and 2021.